Peter Jeffrey Snyder, Ph.D.
Affiliations: | 2008-2018 | Neurology | Warren Alpert Medical School of Brown University, Providence, RI, United States |
| 2018- | Department of Biomedical & Pharmaceutical Sciences | The University of Rhode Island |
Area:
Neuropsychology, Neuropharmacology, Alzheimer's Disease, History of Neuroscience, Bioethics, NeurophysiologyGoogle:
"Peter J. Snyder"Bio:
Clinical neuropsychologist & neuroscientist, with initial specialty in epilepsy; Associate Prof. of Neurology, MCP & Hahnemann School of Medicine, Pittsburgh, 1994-1998; clinical drug development & discovery of novel biomarkers of neurodegenerative diseases progression - clinician at Pfizer Inc from 1998-2005; Professor of Psychology & Neurology, Univ. of Connecticut, 2005-2008; Visiting Professor, Yale Child Study Center, 2005 - present; Sr. Vice President & Chief Research Officer, Lifespan Hospitals System, Providence, RI, 2008 - 2018; Professor of Clinical Neuroscience (Neurology), Warren Alpert Medical School of Brown University, Providence, RI, 2008 - 2018. Vice President for Research & Professor of Biomedical and Pharmaceutical Sciences, The University of Rhode Island, Kingston, RI, 2018 - present. Scholar-in-Residence, The Rhode Island School of Design, Providence, RI., 2009 - present.
Cross-listing: Neurotree - PsychTree - History of History Tree
Parents
Sign in to add mentor| Jill B. Becker | research assistant | 1984-1986 | University of Michigan (Neurotree) | |
| (Undergraduate Honours Thesis Advisor) | ||||
| Charles Butter | research assistant | 1984-1986 | University of Michigan (Neurotree) | |
| (Undergrad. advisor and Prof. for several courses) | ||||
| William B. Barr | grad student | NYU School of Medicine (Neurotree) | ||
| Lauren Julius Harris | grad student | 1986-1991 | Michigan State (Neurotree) | |
| (Major Professor & Doctoral Committee Chair) | ||||
| Paul Fedio | grad student | 1991-1991 | NIH (Neurotree) | |
| Robert M. Bilder | post-doc | 1992-1994 | Albert Einstein (Neurotree) | |
| (Clinical Neuroscience Post-Doc Fellow) | ||||
| Zaven Khachaturian | research scientist | 1999-2005 | ||
| (Mentor to me, not by formal training, but through informal mentorship in science & AD) | ||||
Children
Sign in to add trainee| Jennifer Renee Cromer | grad student | University of Connecticut (Neurotree) | |
| Brian Harel | grad student | 2000-2004 | University of Connecticut (Neurotree) |
| Robert H. Pietrzak | grad student | 2005-2008 | University of Connecticut (Neurotree) |
| Kathryn Victoria Papp | grad student | 2007-2012 | University of Connecticut (Neurotree) |
| Colleen Elizabeth Jackson | grad student | 2006-2013 | University of Connecticut (Neurotree) |
| Claudia Santos | grad student | 2014-2017 | The University of Rhode Island (Neurotree) |
| Jessica Alber | grad student | 2015-2017 | The University of Rhode Island (Neurotree) |
Collaborators
Sign in to add collaborator| Harry A. Whitaker | collaborator | 1995- | Northern Michigan University (Neurotree) | |
| Paul T. Maruff | collaborator | 1999- | (Neurotree) | |
| (Most important collaborator and best friend) | ||||
| Linda C. Mayes | collaborator | 2001- | Yale School of Medicine (Neurotree) | |
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ravichandran S, Snyder PJ, Alber J, et al. (2024) Quantifying Putative Retinal Gliosis in Preclinical Alzheimer's Disease. Investigative Ophthalmology & Visual Science. 65: 5 |
| Arthur E, Ravichandran S, Snyder PJ, et al. (2023) Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer's disease. Alzheimer's Research & Therapy. 15: 172 |
| Jutten RJ, Thompson L, Sikkes SAM, et al. (2022) A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach. Journal of Alzheimer's Disease : Jad |
| Arthur E, Alber J, Thompson LI, et al. (2021) OCTA reveals remodeling of the peripheral capillary free zones in normal aging. Scientific Reports. 11: 15593 |
| Salloway S, Farlow M, McDade E, et al. (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine |
| Alber J, Arthur E, Goldfarb D, et al. (2021) The relationship between cerebral and retinal microbleeds in cerebral amyloid angiopathy (CAA): A pilot study. Journal of the Neurological Sciences. 423: 117383 |
| Alber J, Arthur E, Sinoff S, et al. (2020) A recommended "minimum data set" framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS). Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12119 |
| Snyder PJ, Alber J, Alt C, et al. (2020) Retinal imaging in Alzheimer's and neurodegenerative diseases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Alber J, Maruff P, Santos CY, et al. (2020) Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay interval. Alzheimer's Research & Therapy. 12: 31 |
| Alber J, Goldfarb D, Thompson LI, et al. (2020) Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 229-243 |